中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(8): 1957-1962

Research advances in the risk factors for infection after liver transplantation

DOI: 10.3969/j.issn.1001-5256.2021.08.046

  • Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, China

Research funding:

Science and Technology Planning Project of Guizhou Province (QKHJC [2020] 1Y302)

  • Received Date: 2020-12-31
  • Accepted Date: 2021-02-01
  • Published Date: 2021-08-20
    Abstract
  • With the continuous development of surgical techniques, liver transplantation has gradually become mature, but postoperative infection remains one of the major causes of failure in liver transplantation. By exploring the risk factors associated with postoperative infection, researchers have found that in addition to the previously reported risk factors, several risk factors which are not discovered or emphasized should be taken seriously. From the aspects of donor-related factors, recipient-related factors, and other factors, this article summarizes the risk factors associated with infection after liver transplantation with reference to the latest advances, so as to provide a theoretical basis for effective prevention and treatment of infection after liver transplantation.

     

    • FullText(HTML)
  • loading
    • References(67)
  • [1]
    ARAVINTHAN AD, BRUNI SG, DOYLE AC, et al. Liver transplantation is a preferable alternative to palliative therapy for selected patients with advanced hepatocellular carcinoma[J]. Ann Surg Oncol, 2017, 24(7): 1843-1851. DOI: 10.1245/s10434-017-5789-3.
    [2]
    IMAI D, YOSHIZUMI T, SAKATA K, et al. Long-term outcomes and risk factors after adult living donor liver transplantation[J]. Transplantation, 2018, 102(9): e382-e391. DOI: 10.1097/TP.0000000000002324.
    [3]
    LI C, WEN TF, MI K, et al. Analysis of infections in the first 3-month after living donor liver transplantation[J]. World J Gastroenterol, 2012, 18(16): 1975-1980. DOI: 10.3748/wjg.v18.i16.1975.
    [4]
    KIM SI. Bacterial infection after liver transplantation[J]. World J Gastroenterol, 2014, 20(20): 6211-6220. DOI: 10.3748/wjg.v20.i20.6211.
    [5]
    PATERNO F, WILSON GC, WIMA K, et al. Hospital utilization and consequences of readmissions after liver transplantation[J]. Surgery, 2014, 156(4): 871-878. DOI: 10.1016/j.surg.2014.06.018.
    [6]
    LIN JW, HAN M, WANG XP, et al. Analysis of clinical features and risk factors of bacteria and fungal infectious complications in early postoperative liver transplant recipients using organ from donation after citizens death[J/CD]. Chin Arch Gen Surg (Electronic Edition), 2016, 10(5): 354-358. DOI: 10.3877/cma.j.issn.1674-0793.2016.05.008.

    林健文, 韩明, 王小平, 等. 公民身后器官捐献肝移植术后早期细菌和真菌感染并发症的临床特点与危险因素分析[J/CD]. 中华普通外科学文献(电子版), 2016, 10(5): 354-358. DOI: 10.3877/cma.j.issn.1674-0793.2016.05.008.
    [7]
    ALTMAN DR, SEBRA R, HAND J, et al. Transmission of methicillin-resistant Staphylococcus aureus via deceased donor liver transplantation confirmed by whole genome sequencing[J]. Am J Transplant, 2014, 14(11): 2640-2644. DOI: 10.1111/ajt.12897.
    [8]
    GRIFFIN GD. The injured brain: TBI, mTBI, the immune system, and infection: Connecting the dots[J]. Mil Med, 2011, 176(4): 364-368. DOI: 10.7205/milmed-d-10-00021.
    [9]
    SHAO WY, HUANG XL, ZHOU HM, et al. Risk factors of DCD donor quality for infection after liver transplantation[J]. J Hepatobiliary Surg, 2018, 26(4): 259-262. DOI: 10.3969/j.issn.1006-4761.2018.04.006.

    邵文雨, 黄新立, 周浩明, 等. DCD供体质量对肝移植术后感染的危险因素分析[J]. 肝胆外科杂志, 2018, 26(4): 259-262. DOI: 10.3969/j.issn.1006-4761.2018.04.006.
    [10]
    SHAO WY, HUANG XL, ZHOU HM, et al. Effect of donation after cardiac death donor quality on receptor survival rate after liver transplantation and analysis of risk factors of infection[J]. J Clin Surg, 2018, 26(12): 913-917. DOI: 10.3969/j.issn.1005-6483.2018.12.007.

    邵文雨, 黄新立, 周浩明, 等. 公民器官捐献供体质量对肝移植术后受体生存率的影响及其感染高危因素分析[J]. 临床外科杂志, 2018, 26(12): 913-917. DOI: 10.3969/j.issn.1005-6483.2018.12.007.
    [11]
    OLIVEIRA RA, TURRINI R, POVEDA VB. Risk factors for development of surgical site infections among liver transplantation recipients: An integrative literature review[J]. Am J Infect Control, 2018, 46(1): 88-93. DOI: 10.1016/j.ajic.2017.05.021.
    [12]
    LIZAOLA-MAYO BC, RODRIGUEZ EA. Cytomegalovirus infection after liver transplantation[J]. World J Transplant, 2020, 10(7): 183-190. DOI: 10.5500/wjt.v10.i7.183.
    [13]
    SANADA Y, KAWANO Y, URAHASHI T, et al. Examinations of ascites from prophylactic drains can predict intra-abdominal infections after living donor liver transplantation[J]. Pediatr Transplant, 2015, 19(6): 595-604. DOI: 10.1111/petr.12549.
    [14]
    YAO S, YAGI S, NAGAO M, et al. Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation[J]. Eur J Clin Microbiol Infect Dis, 2018, 37(10): 1973-1982. DOI: 10.1007/s10096-018-3333-4.
    [15]
    KIM SI, KIM YJ, JUN YH, et al. Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients[J]. Yonsei Med J, 2009, 50(1): 112-121. DOI: 10.3349/ymj.2009.50.1.112.
    [16]
    PIRAT A, OZGUR S, TORGAY A, et al. Risk factors for postoperative respiratory complications in adult liver transplant recipients[J]. Transplant Proc, 2004, 36(1): 218-220. DOI: 10.1016/j.transproceed.2003.11.026.
    [17]
    HE Q, LIU P, LI X, et al. Risk factors of bloodstream infections in recipients after liver transplantation: A meta-analysis[J]. Infection, 2019, 47(1): 77-85. DOI: 10.1007/s15010-018-1230-5.
    [18]
    BUSCH CJ, SIEGLER BH, WERLE H, et al. Risk factors for early viral infections after liver transplantation[J]. Langenbecks Arch Surg, 2018, 403(4): 509-519. DOI: 10.1007/s00423-018-1672-3.
    [19]
    POULADFAR G, JAFARPOUR Z, FIROOZIFAR M, et al. Urinary tract infections among hospitalized adults in the early post-liver transplant period: Prevalence, risk factors, causative agents, and microbial susceptibility[J]. Exp Clin Transplant, 2017, 15(Suppl 1): 190-193. DOI: 10.6002/ect.mesot2016.P68.
    [20]
    LIM S, KIM EJ, LEE TB, et al. Predictors of postoperative infectious complications in liver transplant recipients: Experience of 185 consecutive cases[J]. Korean J Intern Med, 2018, 33(4): 798-806. DOI: 10.3904/kjim.2017.230.
    [21]
    FAGIUOLI S, COLLI A, BRUNO R, et al. Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference[J]. J Hepatol, 2014, 60(5): 1075-1089. DOI: 10.1016/j.jhep.2013.12.021.
    [22]
    SALIBA F, DELVART V, ICHAÏ P, et al. Fungal infections after liver transplantation: Outcomes and risk factors revisited in the MELD era[J]. Clin Transplant, 2013, 27(4): e454-e461. DOI: 10.1111/ctr.12129.
    [23]
    KOU JT, ZHU JQ, FAN H, et al. Clinical predictors of cytomegalovirus infection after liver transplantation[J]. Chin J Surg, 2015, 53(4): 270-273. DOI: 10.3760/cma.j.issn.0529-5815.2015.04.008.

    寇建涛, 朱继巧, 樊华, 等. 肝移植术后巨细胞病毒感染的危险因素分析[J]. 中华外科杂志, 2015, 53(4): 270-273. DOI: 10.3760/cma.j.issn.0529-5815.2015.04.008.
    [24]
    KAIDO T, MORI A, OGURA Y, et al. Pre- and perioperative factors affecting infection after living donor liver transplantation[J]. Nutrition, 2012, 28(11-12): 1104-1108. DOI: 10.1016/j.nut.2012.02.007.
    [25]
    YING Y, LI RD, AI JW, et al. Infection within 2 weeks before liver transplantation closely related to prognosis of posttransplant infection: A single-center retrospective observational study in China[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(4): 358-364. DOI: 10.1016/j.hbpd.2020.06.001.
    [26]
    YANG CH, HE XS, CHEN J, et al. The study of the risk factors of fungal infection after liver transplantation[J]. Natl Med J China, 2012, 92(14): 980-981. DOI: 10.3760/cma.j.issn.0376-2491.2012.14.013.

    杨春华, 何晓顺, 陈娟, 等. 肝移植术后真菌感染危险因素分析[J]. 中华医学杂志, 2012, 92(14): 980-981. DOI: 10.3760/cma.j.issn.0376-2491.2012.14.013.
    [27]
    LAICI C, GAMBERINI L, BARDI T, et al. Early infections in the intensive care unit after liver transplantation-etiology and risk factors: A single-center experience[J]. Transpl Infect Dis, 2018, 20(2): e12834. DOI: 10.1111/tid.12834.
    [28]
    LU JJ, LIU DY, LI HA, et al. The clinical research progress on the risk factors of postoperative infections for patients after liver transplantation[J]. Chin J Nosocomiol, 2018, 28(24): 3836-3840. DOI: 10.11816/cn.ni.2018-186165.

    卢建军, 刘大钺, 李恒爱, 等. 肝移植术后感染影响因素的临床研究进展[J]. 中华医院感染学杂志, 2018, 28(24): 3836-3840. DOI: 10.11816/cn.ni.2018-186165.
    [29]
    ELKHOLY S, MANSOUR DA, EL-HAMID S, et al. Risk index for early infections following living donor liver transplantation[J]. Arch Med Sci, 2019, 15(3): 656-665. DOI: 10.5114/aoms.2019.84736.
    [30]
    HARA T, SOYAMA A, HIDAKA M, et al. Pretransplant serum procalcitonin level for prediction of early post-transplant sepsis in living donor liver transplantation[J]. Hepatol Res, 2018, 48(5): 383-390. DOI: 10.1111/hepr.13043.
    [31]
    NIE K, RAN R, TAN W, et al. Risk factors of intra-abdominal bacterial infection after liver transplantation in patients with hepatocellular carcinoma[J]. Chin J Cancer Res, 2014, 26(3): 309-314. DOI: 10.3978/j.issn.1000-9604.2014.06.10.
    [32]
    TAN YL, SUN LY, ZHU ZJ, et al. Preoperative serum 25-hydroxyvitamin D3 and the incidence of early pulmonary infection after pediatric living donor liver transplantation[J]. Pediatr Pulmonol, 2020, 55(10): 2683-2688. DOI: 10.1002/ppul.24888.
    [33]
    FALLET E, RAYAR M, LANDRIEUX A, et al. Iron metabolism imbalance at the time of listing increases overall and infectious mortality after liver transplantation[J]. World J Gastroenterol, 2020, 26(16): 1938-1949. DOI: 10.3748/wjg.v26.i16.1938.
    [34]
    ROBERTS MB, FISHMAN JA. Immunosuppressive agents and infectious risk in transplantation: Managing the "Net State of Immunosuppression"[J]. Clin Infect Dis, 2020, 17: ciaa1189. DOI: 10.1093/cid/ciaa1189.
    [35]
    LORENZ E, MIRA JP, CORNISH KL, et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection[J]. Infect Immun, 2000, 68(11): 6398-6401. DOI: 10.1128/iai.68.11.6398-6401.2000.
    [36]
    LEE SO, BROWN RA, KANG SH, et al. Toll-like receptor 2 polymorphism and Gram-positive bacterial infections after liver transplantation[J]. Liver Transpl, 2011, 17(9): 1081-1088. DOI: 10.1002/lt.22327.
    [37]
    de MARE-BREDEMEIJER EL, MANCHAM S, UTOMO WK, et al. Genetic polymorphisms in innate immunity receptors do not predict the risk of bacterial and fungal infections and acute rejection after liver transplantation[J]. Transpl Infect Dis, 2013, 15(2): 120-133. DOI: 10.1111/tid.12034.
    [38]
    EL-BENDARY M, NEAMATALLAH M, ELALFY H, et al. The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection[J]. Br J Biomed Sci, 2018, 75(4): 175-181. DOI: 10.1080/09674845.2018.1492186.
    [39]
    ABAD CL, LAHR BD, RAZONABLE RR. Epidemiology and risk factors for infection after living donor liver transplantation[J]. Liver Transpl, 2017, 23(4): 465-477. DOI: 10.1002/lt.24739.
    [40]
    LUM L, LEE A, VU M, et al. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center[J]. Transpl Infect Dis, 2020, 22(6): e13361. DOI: 10.1111/tid.13361.
    [41]
    BASSETTI M, PEGHIN M, CARNELUTTI A, et al. Invasive Candida infections in liver transplant recipients: Clinical features and risk factors for mortality[J]. Transplant Direct, 2017, 3(5): e156. DOI: 10.1097/TXD.0000000000000673.
    [42]
    YOSHIZUMI T, SHIRABE K, IKEGAMI T, et al. Decreased immunoglobulin G levels after living-donor liver transplantation is a risk factor for bacterial infection and sepsis[J]. Transpl Infect Dis, 2014, 16(2): 225-231. DOI: 10.1111/tid.12188.
    [43]
    SHEN YH, FAN J, ZHOU J, et al. Postoperative infection in patients undergoing orthotopic liver transplantation[J]. Chin J Gen Surg, 2007, 22(9): 653-655. DOI: 10.3760/j.issn:1007-631X.2007.09.005.

    沈英皓, 樊嘉, 周俭, 等. 原位肝移植术后感染分析[J]. 中华普通外科杂志, 2007, 22(9): 653-655. DOI: 10.3760/j.issn:1007-631X.2007.09.005.
    [44]
    LI MX, PENG GZ, WANG R, et al. Research updates on infections after liver transplantation[J]. Chin J Hepatobiliary Surg, 2015, 21(7): 494-497. DOI: 10.3760/cma.j.issn.1007-8118.2015.07.018.

    李明霞, 彭贵主, 王忍, 等. 肝移植术后感染研究进展[J]. 中华肝胆外科杂志, 2015, 21(7): 494-497. DOI: 10.3760/cma.j.issn.1007-8118.2015.07.018.
    [45]
    FREIRE MP, SOARES OSHIRO IC, BONAZZI PR, et al. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes[J]. Liver Transpl, 2013, 19(9): 1011-1019. DOI: 10.1002/lt.23682.
    [46]
    PARK J, KIM BW, CHOI HJ, et al. Risk stratification for early bacteremia after living donor liver transplantation: A retrospective observational cohort study[J]. BMC Surg, 2020, 20(1): 2. DOI: 10.1186/s12893-019-0658-6.
    [47]
    JU WQ, HE XS, WU ZP, et al. Evaluation of liver grafts with warm ischemia and with different cold preservation time in liver transplantation[J]. Chin J Dig Surg, 2010, 9(1): 41-43. DOI: 10.3760/cma.j.issn.1673-9752.2010.01.016.

    鞠卫强, 何晓顺, 吴志鹏, 等. 不同冷保存时间的热缺血供肝在肝移植中的疗效[J]. 中华消化外科杂志, 2010, 9(1): 41-43. DOI: 10.3760/cma.j.issn.1673-9752.2010.01.016.
    [48]
    BRUMINHENT J, THONGPRAYOON C, DIERKHISING RA, et al. Risk factors for cytomegalovirus reactivation after liver transplantation: Can pre-transplant cytomegalovirus antibody titers predict outcome?[J]. Liver Transpl, 2015, 21(4): 539-546. DOI: 10.1002/lt.24078.
    [49]
    SHAFIEKHANI M, MIRJALILI M, VAZIN A. Prevalence, risk factors and treatment of the most common gram-negative bacterial infections in liver transplant recipients: A review[J]. Infect Drug Resist, 2019, 12: 3485-3495. DOI: 10.2147/IDR.S226217.
    [50]
    AKTAS A, KAYAALP C, GUNES O, et al. Surgical site infection and risk factors following right lobe living donor liver transplantation in adults: A single-center prospective cohort study[J]. Transpl Infect Dis, 2019, 21(6): e13176. DOI: 10.1111/tid.13176.
    [51]
    DUNCAN M, DEVOLL-ZABROCKI A, ETHEREDGE HR, et al. Blood stream infections in children in the first year after liver transplantation at Wits Donald Gordon Medical Centre, South Africa[J]. Pediatr Transplant, 2020, 24(2): e13660. DOI: 10.1111/petr.13660.
    [52]
    TAI Q, HE XS, HU AB, et al. A 17-year study of bloodstream infection after liver transplantation: Resistance rate, risk factor and mortality of enteroccal bloodstream infectious[J]. Natl Med J China, 2010, 90(46): 3279-3282. DOI: 10.3760/cma.j.issn.0376-2491.2010.46.011.

    邰强, 何晓顺, 胡安斌, 等. 肝移植术后肠球菌血行感染的耐药及危险因素分析[J]. 中华医学杂志, 2010, 90(46): 3279-3282. DOI: 10.3760/cma.j.issn.0376-2491.2010.46.011.
    [53]
    SOYAMA A, KUGIYAMA T, HARA T, et al. Efficacy of an artificial pancreas device for achieving tight perioperative glycemic control in living donor liver transplantation[J]. Artif Organs, 2019, 43(3): 270-277. DOI: 10.1111/aor.13373.
    [54]
    WANG H, ZUO XR, CAO Q. Predictive factors and interventions for prolonged mechanical ventilation after liver transplantation[J]. J Clin Hepatol, 2020, 36(7): 1658-1662. DOI: 10.3969/j.issn.1001-5256.2020.07.047

    王翰, 左祥荣, 曹权. 肝移植术后机械通气时间延长的预测因素及干预措施[J]. 临床肝胆病杂志, 2020, 36(7): 1658-1662. DOI: 10.3969/j.issn.1001-5256.2020.07.047.
    [55]
    JAFARPOUR Z, POULADFAR G, MALEK HOSSEINI SA, et al. Bacterial infections in the early period after liver transplantation in adults: A prospective single-center cohort study[J]. Microbiol Immunol, 2020, 64(6): 407-415. DOI: 10.1111/1348-0421.12785.
    [56]
    BOUCHUT JC, STAMM D, BOILLOT O, et al. Postoperative infectious complications in paediatric liver transplantation: A study of 48 transplants[J]. Paediatr Anaesth, 2001, 11(1): 93-98. DOI: 10.1046/j.1460-9592.2001.00574.x.
    [57]
    DOHNA SCHWAKE C, GUIDDIR T, CUZON G, et al. Bacterial infections in children after liver transplantation: A single-center surveillance study of 345 consecutive transplantations[J]. Transpl Infect Dis, 2020, 22(1): e13208. DOI: 10.1111/tid.13208.
    [58]
    ALI M, ANANTHAKRISHNAN AN, AHMAD S, et al. Clostridium difficile infection in hospitalized liver transplant patients: A nationwide analysis[J]. Liver Transpl, 2012, 18(8): 972-978. DOI: 10.1002/lt.23449.
    [59]
    AFSHARI A, YAGHOBI R, KARIMI MH, et al. Association between interleukin-21, 23 and 27 expression and protein level with cytomegalovirus infection in liver transplant recipients[J]. Int J Organ Transplant Med, 2020, 11(1): 27-34.
    [60]
    ZHOU Q, LI L, CHEN Y, et al. Vitamin D supplementation could reduce the risk of acute cellular rejection and infection in vitamin D deficient liver allograft recipients[J]. Int Immunopharmacol, 2019, 75: 105811. DOI: 10.1016/j.intimp.2019.105811.
    [61]
    SINCLAIR M, GOW PJ, GROSSMANN M, et al. Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score[J]. Liver Transpl, 2016, 22(11): 1482-1490. DOI: 10.1002/lt.24607.
    [62]
    VERA A, CONTRERAS F, GUEVARA F. Incidence and risk factors for infections after liver transplant: Single-center experience at the University Hospital Fundación Santa Fe de Bogotá, Colombia[J]. Transpl Infect Dis, 2011, 13(6): 608-615. DOI: 10.1111/j.1399-3062.2011.00640.x.
    [63]
    DING LM, LI XC, LUO WF, et al. The effect of different nutritional modes during perioperative period on infection early after liver transplantation[J/CD]. Chin J Transplant (Electronic Edition), 2017, 11(4): 211-215. DOI: 10.3877/cma.j.issn.1674-3903.2017.04.004.

    丁利民, 李新长, 罗文峰, 等. 围手术期不同营养方式对肝移植术后早期感染的影响[J/CD]. 中华移植杂志(电子版), 2017, 11(4): 211-215. DOI: 10.3877/cma.j.issn.1674-3903.2017.04.004.
    [64]
    NAGAO M, FUJIMOTO Y, YAMAMOTO M, et al. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis[J]. J Infect Chemother, 2016, 22(2): 84-89. DOI: 10.1016/j.jiac.2015.11.005.
    [65]
    SUN Y, ZHENG H, ZHANG JL, et al. Clinical characteristics of carbapenem-resistant Enterobacteriaceae infection in pediatric liver transplantation recipients[J]. Chin J Pediatr, 2020, 58(8): 640-645. DOI: 10.3760/cma.j.cn112140-20200316-00239.

    孙雁, 郑虹, 张坚磊, 等. 儿童肝移植术后耐碳青霉烯类肠杆菌科感染临床特点分析[J]. 中华儿科杂志, 2020, 58(8): 640-645. DOI: 10.3760/cma.j.cn112140-20200316-00239.
    [66]
    SELIMOǦLU MA, KAYA S, GÜNGÖR Ș, et al. Infection risk after paediatric liver transplantation[J]. Turk J Pediatr, 2020, 62(1): 46-52. DOI: 10.24953/turkjped.2020.01.007.
    [67]
    KIM W, KIM S, OH J, et al. Incidence and risk factors for herpes zoster after adult liver transplantation[J]. Ann Surg Treat Res, 2019, 96(2): 95-99. DOI: 10.4174/astr.2019.96.2.95.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (577) PDF downloads(79) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return